New research identifies a previously unknown enzymatic mechanism that subverts the early host immune response and promotes pathogenicity by manipulating a common signaling pathway in host cells. The research may have important implications for the food industry and for development of new antibiotics. In addition, the results lead to intriguing questions about whether mammalian cells can make use of a similar mechanism for potentially permanent and irreversible post-translational modifications.